Gene Therapy Drugs Market

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gene Therapy Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Neuromuscular Disease
        1.2.3 Genetic Disease
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Gene Therapy Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gene Therapy Drugs Market Perspective (2017-2028)
    2.2 Gene Therapy Drugs Growth Trends by Region
        2.2.1 Gene Therapy Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gene Therapy Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Gene Therapy Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Gene Therapy Drugs Market Dynamics
        2.3.1 Gene Therapy Drugs Industry Trends
        2.3.2 Gene Therapy Drugs Market Drivers
        2.3.3 Gene Therapy Drugs Market Challenges
        2.3.4 Gene Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gene Therapy Drugs Players by Revenue
        3.1.1 Global Top Gene Therapy Drugs Players by Revenue (2017-2022)
        3.1.2 Global Gene Therapy Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gene Therapy Drugs Revenue
    3.4 Global Gene Therapy Drugs Market Concentration Ratio
        3.4.1 Global Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Drugs Revenue in 2021
    3.5 Gene Therapy Drugs Key Players Head office and Area Served
    3.6 Key Players Gene Therapy Drugs Product Solution and Service
    3.7 Date of Enter into Gene Therapy Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Drugs Breakdown Data by Type
    4.1 Global Gene Therapy Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Gene Therapy Drugs Forecasted Market Size by Type (2023-2028)
5 Gene Therapy Drugs Breakdown Data by Application
    5.1 Global Gene Therapy Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Gene Therapy Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gene Therapy Drugs Market Size (2017-2028)
    6.2 North America Gene Therapy Drugs Market Size by Type
        6.2.1 North America Gene Therapy Drugs Market Size by Type (2017-2022)
        6.2.2 North America Gene Therapy Drugs Market Size by Type (2023-2028)
        6.2.3 North America Gene Therapy Drugs Market Share by Type (2017-2028)
    6.3 North America Gene Therapy Drugs Market Size by Application
        6.3.1 North America Gene Therapy Drugs Market Size by Application (2017-2022)
        6.3.2 North America Gene Therapy Drugs Market Size by Application (2023-2028)
        6.3.3 North America Gene Therapy Drugs Market Share by Application (2017-2028)
    6.4 North America Gene Therapy Drugs Market Size by Country
        6.4.1 North America Gene Therapy Drugs Market Size by Country (2017-2022)
        6.4.2 North America Gene Therapy Drugs Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Gene Therapy Drugs Market Size (2017-2028)
    7.2 Europe Gene Therapy Drugs Market Size by Type
        7.2.1 Europe Gene Therapy Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Gene Therapy Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Gene Therapy Drugs Market Share by Type (2017-2028)
    7.3 Europe Gene Therapy Drugs Market Size by Application
        7.3.1 Europe Gene Therapy Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Gene Therapy Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Gene Therapy Drugs Market Share by Application (2017-2028)
    7.4 Europe Gene Therapy Drugs Market Size by Country
        7.4.1 Europe Gene Therapy Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Gene Therapy Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Gene Therapy Drugs Market Size by Type
        8.2.1 Asia-Pacific Gene Therapy Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Gene Therapy Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Gene Therapy Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Gene Therapy Drugs Market Size by Application
        8.3.1 Asia-Pacific Gene Therapy Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Gene Therapy Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Gene Therapy Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Gene Therapy Drugs Market Size by Region
        8.4.1 Asia-Pacific Gene Therapy Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Gene Therapy Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Gene Therapy Drugs Market Size (2017-2028)
    9.2 Latin America Gene Therapy Drugs Market Size by Type
        9.2.1 Latin America Gene Therapy Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Gene Therapy Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Gene Therapy Drugs Market Share by Type (2017-2028)
    9.3 Latin America Gene Therapy Drugs Market Size by Application
        9.3.1 Latin America Gene Therapy Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Gene Therapy Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Gene Therapy Drugs Market Share by Application (2017-2028)
    9.4 Latin America Gene Therapy Drugs Market Size by Country
        9.4.1 Latin America Gene Therapy Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Gene Therapy Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Gene Therapy Drugs Market Size by Type
        10.2.1 Middle East & Africa Gene Therapy Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Gene Therapy Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Gene Therapy Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Gene Therapy Drugs Market Size by Application
        10.3.1 Middle East & Africa Gene Therapy Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Gene Therapy Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Gene Therapy Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Gene Therapy Drugs Market Size by Country
        10.4.1 Middle East & Africa Gene Therapy Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Gene Therapy Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 F. Hoffmann-La Roche AG
        11.1.1 F. Hoffmann-La Roche AG Company Details
        11.1.2 F. Hoffmann-La Roche AG Business Overview
        11.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Introduction
        11.1.4 F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2017-2022)
        11.1.5 F. Hoffmann-La Roche AG Recent Developments
    11.2 Novartis International AG
        11.2.1 Novartis International AG Company Details
        11.2.2 Novartis International AG Business Overview
        11.2.3 Novartis International AG Gene Therapy Drugs Introduction
        11.2.4 Novartis International AG Revenue in Gene Therapy Drugs Business (2017-2022)
        11.2.5 Novartis International AG Recent Developments
    11.3 Gilead Sciences, Inc.
        11.3.1 Gilead Sciences, Inc. Company Details
        11.3.2 Gilead Sciences, Inc. Business Overview
        11.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Introduction
        11.3.4 Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2017-2022)
        11.3.5 Gilead Sciences, Inc. Recent Developments
    11.4 Ultragenyx Pharmaceutical,Inc.
        11.4.1 Ultragenyx Pharmaceutical,Inc. Company Details
        11.4.2 Ultragenyx Pharmaceutical,Inc. Business Overview
        11.4.3 Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Introduction
        11.4.4 Ultragenyx Pharmaceutical,Inc. Revenue in Gene Therapy Drugs Business (2017-2022)
        11.4.5 Ultragenyx Pharmaceutical,Inc. Recent Developments
    11.5 Applied Genetic Technologies Corp
        11.5.1 Applied Genetic Technologies Corp Company Details
        11.5.2 Applied Genetic Technologies Corp Business Overview
        11.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Introduction
        11.5.4 Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2017-2022)
        11.5.5 Applied Genetic Technologies Corp Recent Developments
    11.6 Audentes Therapeutics
        11.6.1 Audentes Therapeutics Company Details
        11.6.2 Audentes Therapeutics Business Overview
        11.6.3 Audentes Therapeutics Gene Therapy Drugs Introduction
        11.6.4 Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
        11.6.5 Audentes Therapeutics Recent Developments
    11.7 BioMarin Pharmaceutical
        11.7.1 BioMarin Pharmaceutical Company Details
        11.7.2 BioMarin Pharmaceutical Business Overview
        11.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Introduction
        11.7.4 BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2017-2022)
        11.7.5 BioMarin Pharmaceutical Recent Developments
    11.8 Bluebird Bio
        11.8.1 Bluebird Bio Company Details
        11.8.2 Bluebird Bio Business Overview
        11.8.3 Bluebird Bio Gene Therapy Drugs Introduction
        11.8.4 Bluebird Bio Revenue in Gene Therapy Drugs Business (2017-2022)
        11.8.5 Bluebird Bio Recent Developments
    11.9 Nightstar Therapeutics
        11.9.1 Nightstar Therapeutics Company Details
        11.9.2 Nightstar Therapeutics Business Overview
        11.9.3 Nightstar Therapeutics Gene Therapy Drugs Introduction
        11.9.4 Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
        11.9.5 Nightstar Therapeutics Recent Developments
    11.10 Sangamo Therapeutics
        11.10.1 Sangamo Therapeutics Company Details
        11.10.2 Sangamo Therapeutics Business Overview
        11.10.3 Sangamo Therapeutics Gene Therapy Drugs Introduction
        11.10.4 Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
        11.10.5 Sangamo Therapeutics Recent Developments
    11.11 Spark Therapeutics
        11.11.1 Spark Therapeutics Company Details
        11.11.2 Spark Therapeutics Business Overview
        11.11.3 Spark Therapeutics Gene Therapy Drugs Introduction
        11.11.4 Spark Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
        11.11.5 Spark Therapeutics Recent Developments
    11.12 uniQure
        11.12.1 uniQure Company Details
        11.12.2 uniQure Business Overview
        11.12.3 uniQure Gene Therapy Drugs Introduction
        11.12.4 uniQure Revenue in Gene Therapy Drugs Business (2017-2022)
        11.12.5 uniQure Recent Developments
    11.13 VBL Therapeutics
        11.13.1 VBL Therapeutics Company Details
        11.13.2 VBL Therapeutics Business Overview
        11.13.3 VBL Therapeutics Gene Therapy Drugs Introduction
        11.13.4 VBL Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
        11.13.5 VBL Therapeutics Recent Developments
    11.14 Voyager Therapeutics
        11.14.1 Voyager Therapeutics Company Details
        11.14.2 Voyager Therapeutics Business Overview
        11.14.3 Voyager Therapeutics Gene Therapy Drugs Introduction
        11.14.4 Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
        11.14.5 Voyager Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Gene Therapy Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Neuromuscular Disease
    Table 3. Key Players of Genetic Disease
    Table 4. Key Players of Other
    Table 5. Global Gene Therapy Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Gene Therapy Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Gene Therapy Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Gene Therapy Drugs Market Share by Region (2017-2022)
    Table 9. Global Gene Therapy Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Gene Therapy Drugs Market Share by Region (2023-2028)
    Table 11. Gene Therapy Drugs Market Trends
    Table 12. Gene Therapy Drugs Market Drivers
    Table 13. Gene Therapy Drugs Market Challenges
    Table 14. Gene Therapy Drugs Market Restraints
    Table 15. Global Gene Therapy Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Gene Therapy Drugs Revenue Share by Players (2017-2022)
    Table 17. Global Top Gene Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Drugs as of 2021)
    Table 18. Ranking of Global Top Gene Therapy Drugs Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Gene Therapy Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Gene Therapy Drugs Product Solution and Service
    Table 22. Date of Enter into Gene Therapy Drugs Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Gene Therapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Gene Therapy Drugs Revenue Market Share by Type (2017-2022)
    Table 26. Global Gene Therapy Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Gene Therapy Drugs Revenue Market Share by Type (2023-2028)
    Table 28. Global Gene Therapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Gene Therapy Drugs Revenue Share by Application (2017-2022)
    Table 30. Global Gene Therapy Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Gene Therapy Drugs Revenue Share by Application (2023-2028)
    Table 32. North America Gene Therapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Gene Therapy Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Gene Therapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Gene Therapy Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Gene Therapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Gene Therapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Gene Therapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Gene Therapy Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Gene Therapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Gene Therapy Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Gene Therapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Gene Therapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Gene Therapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Gene Therapy Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Gene Therapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Gene Therapy Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Gene Therapy Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Gene Therapy Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Gene Therapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Gene Therapy Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Gene Therapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Gene Therapy Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Gene Therapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Gene Therapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Gene Therapy Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Gene Therapy Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Gene Therapy Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Gene Therapy Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Gene Therapy Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Gene Therapy Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 62. F. Hoffmann-La Roche AG Company Details
    Table 63. F. Hoffmann-La Roche AG Business Overview
    Table 64. F. Hoffmann-La Roche AG Gene Therapy Drugs Product
    Table 65. F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 66. F. Hoffmann-La Roche AG Recent Developments
    Table 67. Novartis International AG Company Details
    Table 68. Novartis International AG Business Overview
    Table 69. Novartis International AG Gene Therapy Drugs Product
    Table 70. Novartis International AG Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 71. Novartis International AG Recent Developments
    Table 72. Gilead Sciences, Inc. Company Details
    Table 73. Gilead Sciences, Inc. Business Overview
    Table 74. Gilead Sciences, Inc. Gene Therapy Drugs Product
    Table 75. Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 76. Gilead Sciences, Inc. Recent Developments
    Table 77. Ultragenyx Pharmaceutical,Inc. Company Details
    Table 78. Ultragenyx Pharmaceutical,Inc. Business Overview
    Table 79. Ultragenyx Pharmaceutical,Inc. Gene Therapy Drugs Product
    Table 80. Ultragenyx Pharmaceutical,Inc. Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 81. Ultragenyx Pharmaceutical,Inc. Recent Developments
    Table 82. Applied Genetic Technologies Corp Company Details
    Table 83. Applied Genetic Technologies Corp Business Overview
    Table 84. Applied Genetic Technologies Corp Gene Therapy Drugs Product
    Table 85. Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 86. Applied Genetic Technologies Corp Recent Developments
    Table 87. Audentes Therapeutics Company Details
    Table 88. Audentes Therapeutics Business Overview
    Table 89. Audentes Therapeutics Gene Therapy Drugs Product
    Table 90. Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 91. Audentes Therapeutics Recent Developments
    Table 92. BioMarin Pharmaceutical Company Details
    Table 93. BioMarin Pharmaceutical Business Overview
    Table 94. BioMarin Pharmaceutical Gene Therapy Drugs Product
    Table 95. BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 96. BioMarin Pharmaceutical Recent Developments
    Table 97. Bluebird Bio Company Details
    Table 98. Bluebird Bio Business Overview
    Table 99. Bluebird Bio Gene Therapy Drugs Product
    Table 100. Bluebird Bio Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 101. Bluebird Bio Recent Developments
    Table 102. Nightstar Therapeutics Company Details
    Table 103. Nightstar Therapeutics Business Overview
    Table 104. Nightstar Therapeutics Gene Therapy Drugs Product
    Table 105. Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 106. Nightstar Therapeutics Recent Developments
    Table 107. Sangamo Therapeutics Company Details
    Table 108. Sangamo Therapeutics Business Overview
    Table 109. Sangamo Therapeutics Gene Therapy Drugs Product
    Table 110. Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 111. Sangamo Therapeutics Recent Developments
    Table 112. Spark Therapeutics Company Details
    Table 113. Spark Therapeutics Business Overview
    Table 114. Spark Therapeutics Gene Therapy Drugs Product
    Table 115. Spark Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 116. Spark Therapeutics Recent Developments
    Table 117. uniQure Company Details
    Table 118. uniQure Business Overview
    Table 119. uniQure Gene Therapy Drugs Product
    Table 120. uniQure Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 121. uniQure Recent Developments
    Table 122. VBL Therapeutics Company Details
    Table 123. VBL Therapeutics Business Overview
    Table 124. VBL Therapeutics Gene Therapy Drugs Product
    Table 125. VBL Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 126. VBL Therapeutics Recent Developments
    Table 127. Voyager Therapeutics Company Details
    Table 128. Voyager Therapeutics Business Overview
    Table 129. Voyager Therapeutics Gene Therapy Drugs Product
    Table 130. Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022) & (US$ Million)
    Table 131. Voyager Therapeutics Recent Developments
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Therapy Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Neuromuscular Disease Features
    Figure 3. Genetic Disease Features
    Figure 4. Other Features
    Figure 5. Global Gene Therapy Drugs Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Case Studies
    Figure 7. Pharmacy Case Studies
    Figure 8. Gene Therapy Drugs Report Years Considered
    Figure 9. Global Gene Therapy Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Gene Therapy Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Gene Therapy Drugs Market Share by Region: 2021 VS 2028
    Figure 12. Global Gene Therapy Drugs Market Share by Players in 2021
    Figure 13. Global Top Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Drugs as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Gene Therapy Drugs Revenue in 2021
    Figure 15. North America Gene Therapy Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Gene Therapy Drugs Market Size Market Share by Type (2017-2028)
    Figure 17. North America Gene Therapy Drugs Market Size Market Share by Application (2017-2028)
    Figure 18. North America Gene Therapy Drugs Market Size Share by Country (2017-2028)
    Figure 19. United States Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Gene Therapy Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Gene Therapy Drugs Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Gene Therapy Drugs Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Gene Therapy Drugs Market Size Share by Country (2017-2028)
    Figure 25. Germany Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Gene Therapy Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Gene Therapy Drugs Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Gene Therapy Drugs Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Gene Therapy Drugs Market Size Share by Region (2017-2028)
    Figure 35. China Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Gene Therapy Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Gene Therapy Drugs Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Gene Therapy Drugs Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Gene Therapy Drugs Market Size Share by Country (2017-2028)
    Figure 45. Mexico Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Gene Therapy Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Gene Therapy Drugs Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Gene Therapy Drugs Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Gene Therapy Drugs Market Size Share by Country (2017-2028)
    Figure 51. Turkey Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Gene Therapy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. F. Hoffmann-La Roche AG Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 55. Novartis International AG Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 56. Gilead Sciences, Inc. Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 57. Ultragenyx Pharmaceutical,Inc. Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 58. Applied Genetic Technologies Corp Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 59. Audentes Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 60. BioMarin Pharmaceutical Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 61. Bluebird Bio Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 62. Nightstar Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 63. Sangamo Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 64. Spark Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 65. uniQure Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 66. VBL Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 67. Voyager Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed